Featured Articles

31. Gov. Gretchen Whitmer Announces West Contract Manufacturing Expansion Creating 110 Jobs In West Michigan 1/31/2022

    Gov. Gretchen Whitmer joined the Michigan Economic Development Corporation (MEDC) today to announce that West Pharmaceutical Services, Inc., through its subsidiary West Contract Manufacturing (West), plans to expand in the city of Walker, where it will create up to 110 jobs for Michigan workers.

32. West Announces Landmark Collaboration With Corning In Pharmaceutical Injectable Drug Delivery 1/26/2022

    The exclusive long-term supply and development agreement includes a multimillion-dollar capital and R&D investment in Corning to enable advanced drug containment and delivery system solutions.

33. West Pharmaceuticals And MEDX Xelerator Sign Strategic Collaboration 11/23/2021

    The agreement is focused on identifying and developing early-stage medical technology innovation. Under the terms of the accord, West will provide funding for joint venture creations at the incubator and will have the option to further invest in these same projects, alongside the incubator, if the projects mature into portfolio companies.

34. West Launches New Vial2Bag Advanced™ 20mm Admixture Device 10/22/2020

    West Pharmaceutical Services, Inc. (NYSE: WST), West Pharmaceutical Services, Inc. (West) is pleased to announce FDA 510(k) clearance and launch of its Vial2Bag Advanced™ 20mm Admixture Device.

35. West Expands NovaGuard™ Platform of Products for Safe and Effective Injectable Drug Delivery 7/2/2013

    West Pharmaceutical Services, Inc., a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products.

36. West And Janssen Biotech Agreement To Develop A New Self-injection Technology 9/5/2012

    West Pharmaceutical Services announced an agreement with Janssen Biotech, Inc. to collaborate on the development and manufacturing of an innovative self-injection product. 

37. Holistic QbD: A Key To Improved Profitability And Sustained Competitive Advantage With Sterile Pharmaceutical Products 8/9/2012

    Pharmaceutical companies are faced with assuring that new quality and compliance paradigms can be met while facilitating profitability to continue adequate business reinvestment. By Fran DeGrazio, Vice President, Global Research and Development, Pharmaceutical Packaging Systems West Pharmaceutical Services, Inc.

38. Sterilization Of Ready-To-Use Components 12/2/2011

    Inadequate aseptic processing operations, human error, high endotoxin levels, microbial contamination and insufficient sterility testing have all generated FDA warning letters.

39. Packaging/Delivery System Integrity And Self-Sealing Capacity Of Vial Systems

    Review the scope and testing procedures required by General Chapter USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems.

40. Benefits Of QbD: Considerations For Drug-Device Combination Products And Partnerships

    Quality by Design (QbD) achieves quality through understanding of all components and processes, with a detailed understanding of risks and how they can be mitigated.